Q

Qiagen NV
D

QGEN

48.270
USD
-0.36
(-0.74%)
مغلق
حجم التداول
41,930
الربح لكل سهم
2
العائد الربحي
0.52
P/E
112
حجم السوق
10,453,171,105
أصول ذات صلة
NEOUSD
NEOUSD
-0.09272
(-1.71%)
5.34111 USD
BDX
BDX
-0.560
(-0.32%)
176.660 USD
C
CRL
-0.270
(-0.17%)
157.160 USD
DGX
DGX
-0.610
(-0.35%)
176.010 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
HOLX
HOLX
-0.540
(-0.83%)
64.750 USD
IQV
IQV
-1.560
(-0.95%)
163.120 USD
LH
LH
-0.99
(-0.38%)
259.12 USD
N
NEO
0.15000
(2.03%)
7.54000 USD
TMO
TMO
1.69
(0.40%)
429.33 USD
المزيد
الأخبار المقالات

العنوان: Qiagen N.V.

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).